Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Bioavailability
Interventions
DRUG

Dronabinol Capsules, 5 mg

Comparison of different routes of administration of a drug using the approved Abbott 5 mg capsule product under fasting conditions; two treatment periods with a washout period separating the study periods

DRUG

Dronabinol Oral Solution

Comparison of different routes of administration of a drug using a proposed oral solution formulation under fasting conditions; two treatment periods with a washout period separating the study periods

Trial Locations (1)

78754

Worldwide Clinical Trials Drug Development Solutions, Austin

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY